This finding positions GARP as a novel molecular mediator of PM2.5-induced EMT, suggesting that targeting GARP could be an avenue to mitigating the deleterious effects of PM2.5 exposure in respiratory diseases and other related conditions. This evidence concerns the gene LRRC32 and respiratory system disorder.